Self-selection of P medicines - not in the public interest!

The new pharmacy regulator, the General Pharmaceutical Council (GPhC) has publicly stated that its expertise is in regulation and not in pharmacy practice. Despite this admission, and the strong representations from representative bodies within the profession, it is proposing without consultation, to fundamentally change pharmacy practice in the way the most potent medicines are sold to the public.

We believe that selling potent medicines on an open display puts patient safety at risk and the GPhC’s proposals, which will enable P category medicines to be made available through self-selection, must be withdrawn.

Click here to read more about why the PDA are concerned about these proposals

Sponsor

The Pharmacists' Defence Association

Links

The PDA

Discussion

  • Lucy Taylor Self selection of P medicines will decrease patient safety, increase hopsital admissions and patients will miss out on important additional advice on the medicines and what they are treating. Also increase thefts of medicines that have the potential to be abused.

  • Bryan Stone I am in full support of maintaining the current status which works. It will be the start of the end for us if they go ahead. Needs to be stopped.

  • Anonymous We are told that we need to be more stringent on people abusing OTC medicines, yet the GPhC is proposing to put P meds out for self selection...it just doesn't make any sense at all

join the discussion

Recent signatures

  • username

    Laura McCoubrey

    10 hours ago Comments: -
  • username

    Chris Smith

    17 hours ago Comments: If this is allowed to go through, it will cause chaos and will be massively detrimental to pharmacist and patients alike. Imagine trying to stop a patient from purchasing multiple packs and then them slamming the money down and walking out. It would be impossible to police and everyone EXCEPT multiple pharmacies would suffer
  • username

    Karishma Chandrahas

    6 days ago Comments: -
See more

Petition highlights

There are no highlights yet.